Agilon Health Inc. (AGL) Tops Q1 EPS by 3c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
Tweet
Share
E-mail
Get Alerts AGL Hot Sheet
Join SI Premium – FREE
Agilon Health Inc. (NYSE: AGL) reported Q1 EPS of $0.03, $0.03 better than the analyst estimate of $0.00. Revenue for the quarter came in at $1.53 billion versus the consensus estimate of $1.51 billion.
GUIDANCE:
Agilon Health Inc. sees Q2 2025 revenue of $1.43-1.5 billion, versus the consensus of $1.48 billion.
Agilon Health Inc. sees FY2025 revenue of $5.85-6.02 billion, versus the consensus of $5.91 billion.
For earnings history and earnings-related data on Agilon Health Inc. (AGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Levi (LEVI) Tops Q3 EPS by 12c; raises guidance
- Applied Digital (APLD) Tops Q1 EPS by 26c, Beats on Revenue
- MicroVision reaffirms 2026 revenue guidance, projects double in 2027
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
